HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru.

AbstractOBJECTIVES:
To determine the sensitivity of the bacillus Calmette-Guérin (BCG) scar as an indicator of previous vaccination and to ascertain the tuberculin skin test (TST) response in infancy after vaccination in a community from an area hyperendemic for tuberculosis (TB).
METHODS:
In a birth cohort of healthy term infants from Lima, Peru, a single dose of BCG vaccine was administered within the first month of life. Scar formation was assessed biweekly during the first 6 months and again at 3 years after vaccination. TST response was evaluated 6 months after vaccination.
RESULTS:
Six months after vaccination, 99% (68) of the newborns exhibited a BCG scar (>2 mm). Scar size did not differ by sex, birth weight, age at vaccination, or nutritional status in the first 2 months. Eighty percent of the participants were found 3 years after vaccination, and all of them had a BCG scar. Mean TST reaction size 6 months after vaccination was 2.9 +/- 0.3 mm. No association was found between sex or age at BCG vaccination and TST size. Only 3 children had a TST >10 mm, and the 3 had a TB contact at home.
CONCLUSIONS:
The BCG scar was a sensitive indicator of vaccination status up to 3 years after the administration of the vaccine in the first month of life. Although nearly a quarter of the children had a TST response >5 mm 6 months after vaccination, TST reactions >10 mm did not occur in the absence of exposure to a person with tuberculosis. A cutoff of 10 mm should be used for disease control purposes in people who are born in countries where TB is endemic.
AuthorsEunice M Santiago, Elise Lawson, Kari Gillenwater, Sheela Kalangi, Andrés G Lescano, Gregory Du Quella, Kristin Cummings, Lilia Cabrera, Cecilia Torres, Robert H Gilman
JournalPediatrics (Pediatrics) Vol. 112 Issue 4 Pg. e298 (Oct 2003) ISSN: 1098-4275 [Electronic] United States
PMID14523215 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Bacterial
  • BCG Vaccine
Topics
  • Antibodies, Bacterial (biosynthesis)
  • BCG Vaccine (immunology)
  • Cicatrix (epidemiology, etiology)
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Growth Disorders (epidemiology, immunology)
  • Humans
  • Infant, Newborn
  • Male
  • Mycobacterium tuberculosis (immunology)
  • Nutrition Disorders (epidemiology, immunology)
  • Peru (epidemiology)
  • Poverty Areas
  • Prospective Studies
  • Seroepidemiologic Studies
  • Tuberculin Test (statistics & numerical data)
  • Vaccination (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: